Aflac (AFL) Q2 2026 Earnings Call Transcript

Aflac reported Q2 2026 net earnings per diluted share of $1.63 (+46.8% YoY) and adjusted EPS of $1.75 (down 1.7% YoY, hurt by a -$0.05 FX impact from a 9.3% weaker yen), while adjusted EPS was $1.80 on a currency-neutral basis (+1.1%). Total revenues were $4.1B (-1% YoY), but capital deployment remained strong with $1.3B returned to shareholders in the quarter ($983M buybacks, $309M dividends) and unencumbered liquidity at $3.3B. Japan earnings were supported by a higher pretax margin (34.3%, +230 bps YoY) and a benefit ratio expected to settle at the high end of 2026 guidance (60%–63%), though U.S. net earned premium growth is now expected to run just below the 3%–6% range for 2026.

Analysis

The market should focus less on the quarterly EPS print and more on the capital-engine reset. The combination of higher-yield asset rotation, expanded reinsurance capacity, and ongoing buybacks creates a cleaner path to ROE expansion than the underlying sales line alone suggests. That matters because AFL has historically traded like a low-growth insurer; if management can convert balance-sheet optionality into even modest NII uplift and capital release, the multiple can re-rate before the P&L fully catches up.

Near term, the cleanest loser is not an obvious competitor but AFL’s own earnings quality: reported margins are being flattered by reserve/mix dynamics that may normalize, while U.S. disability claims and Japan lapse/reissue noise can keep quarterly results choppy. Over 1-3 months, the key catalyst is whether the Q3 assumption review validates management’s claim that the Japan benefit ratio can drift back inside range; if it does not, investors will start treating the current margin story as timing rather than underwriting improvement. Over 6-18 months, a sustained stronger yen would cut translation gains and reduce the portfolio-switching windfall, partially offsetting the capital-return story.

Contrarian take: the consensus may be underestimating how much of AFL’s value now comes from financial engineering rather than organic premium growth. That is bullish if rates stay elevated and reinsurance execution remains consistent, but it is also the thesis’ weak point—if JGB yields rise too quickly, or if Japanese inflation lifts expense ratios faster than expected, the current playbook loses torque. For competitors, the second-order effect is that AFL’s first-sector-led customer acquisition could pressure Japan supplemental insurers and U.S. voluntary-benefits peers by improving cross-sell economics, even if AFL’s own top-line growth stays mid-single-digit.

Key Decisions for Investors

• Long AFL on pullbacks over the next 2-6 weeks; thesis is ROE accretion from reinsurance + portfolio repositioning, with downside limited by capital return and strong liquidity. Falsify if Q3 assumption review shows Japan benefit ratio stays stuck above the high end of guidance.
• Pair trade: long AFL / short broader U.S. life-insurance proxy (KIE or XLF if sector liquidity is preferred) for 3-6 months. AFL has a cleaner catalyst path from capital actions; the short leg hedges sector beta if the move was just an earnings-day relief rally.
• Buy a 3-6 month AFL call spread rather than outright calls if you expect gradual multiple expansion, not a straight-line earnings beat. Best entry is on any post-call fade; the risk/reward improves if the stock gives back the initial move while management keeps signaling more asset-switch activity.
• Watch item, not a trade: if yen strengthens materially from current levels, trim the bullish thesis because FX-related portfolio gains and reported EPS tailwinds will fade even if underlying economics hold.
• If you already own AFL, use a trailing stop under the pre-earnings base rather than chasing upside; the next inflection is likely operational confirmation in Q3, not immediate incremental news.